Centogene N.V.
CNTG
Price:
$0.325
Market Cap:
$7.87M
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and ide...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-11-07
Stock Exchange
NASDAQ
Ticker
CNTG
PE Ratio
[-0.23]
ROE
[397.65%]
Current Ratio
[1.02]
Dividend Yield
[0%]
Enterprise Value
[70.10M]
Dividend History
The ROE as of July 2025 (TTM) for Centogene N.V. (CNTG) is 397.65%
According to Centogene N.V.’s latest financial reports and current stock price. The company's current ROE is 397.65%. This represents a change of 890.03% compared to the average of 40.17% of the last 4 quarters.
Centogene N.V. (CNTG) Historical ROE (quarterly & annually)
How has CNTG ROE performed in the past?
The mean historical ROE of Centogene N.V. over the last ten years is -97.38%. The current 397.65% ROE has changed -508.34% with respect to the historical average. Over the past ten years (40 quarters), CNTG's ROE was at its highest in in the April 2023 quarter at 80.33%. The ROE was at its lowest in in the November 2022 quarter at -105.49%.
Average
-97.38%
Median
-38.20%
Minimum
-429.65%
Maximum
140.54%
Centogene N.V. (CNTG) ROE by Quarter and Year
Discovering the peaks and valleys of Centogene N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 413.53%
Maximum Annual ROE = 140.54%
Minimum Annual Increase = -132.71%
Minimum Annual ROE = -429.65%
| Year | ROE | Change |
|---|---|---|
| 2023 | 140.54% | -132.71% |
| 2022 | -429.65% | 153.72% |
| 2021 | -169.34% | 413.53% |
| 2020 | -32.97% | -5.35% |
| 2019 | -34.84% | -16.17% |
| 2018 | -41.56% | 27.02% |
| 2017 | -32.72% | -81.67% |
Centogene N.V. (CNTG) Average ROE
How has CNTG ROE performed in the past?
The current ROE of Centogene N.V. (CNTG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-152.81%
5-year avg
-105.25%
10-year avg
-97.38%
Centogene N.V. (CNTG) ROE vs. Peers
How is CNTG’s ROE compared to its peers?
Centogene N.V.’s ROE is greater than Genetron Holdings Limited (-100.92%), less than FONAR Corporation (8.77%), greater than Exagen Inc. (-133.69%), greater than Sera Prognostics, Inc. (-51.35%), less than Sotera Health Company (5.80%), greater than Olink Holding AB (publ) (-6.93%), greater than MDxHealth S.A. (-534.88%), greater than Inotiv, Inc. (-51.45%), greater than Star Equity Holdings, Inc. (-23.85%), greater than LumiraDx Limited (-1557.76%), greater than Star Equity Holdings, Inc. (-23.85%), greater than Mainz Biomed B.V. (-2269.65%), greater than Biodesix, Inc. (-168.32%), greater than Aclaris Therapeutics, Inc. (-92.41%), greater than Castle Biosciences, Inc. (-1.15%), greater than Prenetics Global Limited (-27.57%),
| Company | ROE | Market cap |
|---|---|---|
| -100.92% | $127.29M | |
| 8.77% | $99.26M | |
| -133.69% | $148.21M | |
| -51.35% | $99.10M | |
| 5.80% | $3.23B | |
| -6.93% | $3.24B | |
| -534.88% | $107.90M | |
| -51.45% | $63.55M | |
| -23.85% | $29.56M | |
| -1557.76% | $5.10M | |
| -23.85% | $6.29M | |
| -2269.65% | $7.55M | |
| -168.32% | $44.88M | |
| -92.41% | $164.59M | |
| -1.15% | $544.82M | |
| -27.57% | $107.53M |
Build a custom stock screener for Centogene N.V. (CNTG) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Centogene N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Centogene N.V. (CNTG) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Centogene N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Centogene N.V.'s ROE?
How is the ROE calculated for Centogene N.V. (CNTG)?
What is the highest ROE for Centogene N.V. (CNTG)?
What is the 3-year average ROE for Centogene N.V. (CNTG)?
What is the 5-year average ROE for Centogene N.V. (CNTG)?
How does the current ROE for Centogene N.V. (CNTG) compare to its historical average?